Inactive Instrument
CUSPIS CAP L Share Price Toronto S.E.
Stocks
CUSP.P
CA23168X1078
Specialty Chemicals
OTC Markets Traded| Market Cap | 270M 194M 166M 155M 142M 266M 18.52B 1.83B 715M 9.3B 727M 711M 30.77B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 270M 194M 166M 155M 142M 266M 18.52B 1.83B 715M 9.3B 727M 711M 30.77B | EV / Sales 2026 * |
96.4x | EV / Sales 2027 * | 3.7x |
| Free-Float |
86.13% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +14.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Nicol
CEO | Chief Executive Officer | 51 | 09/08/2016 |
Joshua George
DFI | Director of Finance/CFO | - | 07/04/2024 |
Stuart Watson
PRN | Corporate Officer/Principal | - | 21/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Nicol
BRD | Director/Board Member | 51 | 09/08/2016 |
Robert Galyen
BRD | Director/Board Member | - | 30/06/2023 |
Jack Perkowski
CHM | Chairman | 76 | 23/10/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +14.14% | +41.25% | - | - | 194M | ||
| +1.01% | -6.81% | +70.07% | +17.62% | 5.2B | ||
| -2.27% | -7.22% | -23.00% | -30.85% | 2.81B | ||
| +0.44% | -4.31% | -24.42% | +79.39% | 773M | ||
| -0.73% | +7.82% | +22.10% | +16.38% | 644M | ||
| -0.86% | -3.90% | +5.83% | -44.44% | 616M | ||
| +0.96% | -0.32% | -20.84% | -3.36% | 318M | ||
| -1.07% | -2.46% | -34.71% | -38.47% | 280M | ||
| +2.99% | +0.58% | -43.05% | -33.59% | 227M | ||
| -0.93% | +6.00% | +112.00% | +47.22% | 194M | ||
| Average | +1.37% | -2.82% | +7.11% | +1.10% | 1.23B | |
| Weighted average by Cap. | +0.13% | -5.05% | +26.60% | +3.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.8M 2.01M 1.72M 1.61M 1.47M 2.76M 192M 19.01M 7.41M 96.47M 7.54M 7.37M 319M | 73M 52.33M 44.82M 41.94M 38.39M 72.05M 5.01B 495M 193M 2.52B 196M 192M 8.32B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Specialty Chemicals
















